Is PHVS stock a Buy, Sell, or Hold?

Based on our analysis, PHVS is currently a WAIT with low confidence. 📊 MIXED SIGNALS: PHVS shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of PHVS stock?

Our analysis estimates the fair value range for PHVS to be between $34.26 and $37.10. The current price is $38.02.

What is the analyst price target for PHVS?

The average Wall Street analyst price target for PHVS is $55.93. This implies a potential upside of 47.1% from current levels.

PHVS Stock Analysis: Buy, Sell, or Hold?

PHVS - Pharvaris N.V. Ordinary Shares

Pharmaceutical Preparations

$38.02

0.51 (1.36%) ▲

5d: +6.62%

30d: +4.28%

90d: +18.07%

WAIT

LOW Confidence

Protect Your PHVS Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Aug 11, 2026 0d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 8, 2026 at $38.56 · last confirmed Sep 9, 2026

Strength: 7.3/10

Get Alerted When PHVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: PHVS shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: PHVS is currently trading at $38.02, which is considered extended relative to its 30-day fair value range of $34.26 to $37.10.

Technical Outlook: Technically, PHVS is in a strong uptrend. Immediate support is located at $33.80, while resistance sits at $43.25.

Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $55.93 (+47.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $34.26 - $37.10

Company Quality Score 52/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 51.1%

Protect Your Profits

Holding PHVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
NEUTRAL: Mixed technical signals (47/100)
BULLISH: High volume confirmation
BULLISH: Trading 47.1% below Wall St target ($55.93)
WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $34.26 - $37.10

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $33.80

Resistance Level $43.25

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) -14.07

Wall Street Target $55.93 (+47.1%)

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 12, 2026 4:29 AM ET
Data refreshes hourly during market hours. Next update: 5:29 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is PHVS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Anne Lesage SELL 100 shares 2026-04-23

Johannes Gerardus Chri S… SELL 100 shares 2026-04-23

Peng Lu SELL 100 shares 2026-04-23

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for PHVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BMRN Biomarin Pharmaceutical …	STRONG BUY 29 analysts	$91	58 HOLD
AXSM Axsome Therapeutics Inc	STRONG BUY 19 analysts	$285	56 HOLD
NRIX Nurix Therapeutics Inc	STRONG BUY 18 analysts	$34	60 BUY
BBIO BridgeBio Pharma Inc	STRONG BUY 19 analysts	$109	57 HOLD
RNA Atrium Therapeutics, Inc…	STRONG BUY 15 analysts	$25	55 HOLD

BMRN Biomarin Pharmace…

58 HOLD

AXSM Axsome Therapeuti…

56 HOLD

NRIX Nurix Therapeutic…

60 BUY

BBIO BridgeBio Pharma …

57 HOLD

RNA Atrium Therapeuti…

55 HOLD

Advanced PHVS Option Strategies

Professional options setups generated by AI based on today's PHVS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PHVS

PHVS Technical Chart PHVS Price Prediction PHVS Earnings Date Why is PHVS Moving Today? PHVS Investment Advisor PHVS Fair Price Analyzer PHVS Options Advisor PHVS Options Chain PHVS Options Analysis PHVS Competitors

Pharvaris N.V. Ordinary Shares

Pharmaceutical Preparations

About

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Exchange: XNAS

Market Cap: $1,547,047,005

Employees: 114

Listed Since: 2021-02-05

Website: Visit

CIK: 0001830487

Compare PHVS with Peers

PHVS vs EWTX
Which one to buy?

PHVS vs CGEM
Which one to buy?

PHVS vs IMCR
Which one to buy?

PHVS vs ORIC
Which one to buy?

PHVS vs TYRA
Which one to buy?

Create New Comparison View All Competitors

Tradestie